Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00642044|
Recruitment Status : Unknown
Verified March 2008 by Universidade Federal do Rio de Janeiro.
Recruitment status was: Recruiting
First Posted : March 24, 2008
Last Update Posted : April 23, 2008
|Condition or disease||Intervention/treatment||Phase|
|Keratoconus||Procedure: Corneal Collagen Crosslinking||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Corneal Collagen Crosslinking With Riboflavin for Keratoconus Treatment: A Brazilian Study|
|Study Start Date :||February 2007|
|Estimated Primary Completion Date :||December 2008|
|Estimated Study Completion Date :||December 2009|
The eye with the worst visual acuity receives the treatment. (the other eye serve as control).
Procedure: Corneal Collagen Crosslinking
UV light and Riboflavin eyedrops every 5 minutes for 30 minutes.
No Intervention: B
The eye with the best visual acuity do not receive the treatment.
- Keratometry [ Time Frame: 3 months ]
- BSCVA (Best spectacle corrected visual acuity) [ Time Frame: 3 months ]
- Endothelial cell count [ Time Frame: 3 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00642044
|Contact: Ricardo Lamy, MDemail@example.com|
|Clementino Fraga Filho University Hospital||Recruiting|
|Rio de Janeiro, RJ, Brazil, 21941-913|
|Contact: Ricardo Lamy firstname.lastname@example.org|
|Principal Investigator: Ricardo Lamy, MD|
|Principal Investigator:||Ricardo Lamy, MD||UFRJ|